Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotype by Janine Kimpel, Dorothee von Laer, Theresa Schwaiger, Guido Wollmann, Jasmin Hatami, Krishna Das, Leonie Wolf, Andreas Aufschnaiter, Tobias Nolden, Liesa-Marie Schreiber, Brigitte Müllauer, Elke Podgorschek, Bart Spiesschaert, Knut Elbers, Zoltán Bánki

Get full text